Ratcliffe Liam
Director at ARVN; Director at ARRAY BIOPHARMA INC
- Sold, on record
- $71.6M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Dec 16, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ARVNARVINAS, INC.Director
- ARRAY BIOPHARMA INCDirector
Sales by reason
0
Routine
2
Plan not stated
0
No plan
4
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- ARRAY BIOPHARMA INC3.4M shares
- ARVN662,094 shares
Shares sold, every Form 4 sale on record.
Timeline
- Dec 16, 2021Unusual
Sold 65.7% of their holdings
$23.8M355,705 shares at $67.00
- Nov 15, 2021Plan not stated
Sold 19.9% of their holdings
$11.5M134,310 shares at $85.83
- Nov 9, 2021Unusual
Sold 100% of their holdings
$16M172,079 shares at $93.02
- Sep 27, 2013Unusual
Sold 100% of their holdings
$6.8M1.1M shares at $6.00
- Sep 16, 2013Unusual
Sold 59.8% of their holdings
$10.2M1.7M shares at $6.08
- Sep 6, 2013Plan not stated
Sold 17.1% of their holdings
$3.3M577,286 shares at $5.79
6 of 6
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2021 | Dec 16, 2021 | ARVN | Director | Form 4 sale | 355,705 | $23.8M | 65.7% | Unusual | SEC |
| Nov 15, 2021 | Nov 15, 2021 | ARVN | Director | Form 4 sale | 134,310 | $11.5M | 19.9% | Plan not stated | SEC |
| Nov 9, 2021 | Nov 9, 2021 | ARVN | Director | Form 4 sale | 172,079 | $16M | 100.0% | Unusual | SEC |
| Sep 27, 2013 | Sep 30, 2013 | ARRAY BIOPHARMA INC | Director | Form 4 sale | 1.1M | $6.8M | 100.0% | Unusual | SEC |
| Sep 16, 2013 | Sep 16, 2013 | ARRAY BIOPHARMA INC | Director | Form 4 sale | 1.7M | $10.2M | 59.8% | Unusual | SEC |
| Sep 6, 2013 | Sep 6, 2013 | ARRAY BIOPHARMA INC | Director | Form 4 sale | 577,286 | $3.3M | 17.1% | Plan not stated | SEC |